Oncternal Therapeutics
(NASDAQ:ONCT)
$9.05
0.19[2.14%]
At close: May 9
$9.05
0[0.00%]
After Hours: 5:55PM EDT
Q1 2024 Earnings were released on Thu May 9th, after the market close
The most recent conference call was at 17:00 PM, 3 days ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Oncternal Therapeutics Stock (NASDAQ:ONCT), Quotes and News Summary

Oncternal Therapeutics Stock (NASDAQ: ONCT) stock price, news, charts, stock research, profile.

Open$8.210
Close$8.179
Volume / Avg.2.568K / 7.553K
Day Range8.099 - 8.929
52 Wk Range5.566 - 13.140
Market Cap$26.785M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
50
Short Interest
0.48%
Days to Cover1.51

Recent News

Insiders Buying Westlake Chemical Partners And 2 Other Stocks
Although U.S. stocks closed mostly lower on Monday, there were a few notable insider trades.
Avi Kapoor
American Airlines To Rally Around 32%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Avi Kapoor
Top 5 Health Care Stocks That May Crash This Month
As of Jan. 22, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
2
Dec 23
1
Jan
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ONCT
NKGN

FAQ

Q

How do I buy Oncternal Therapeutics (ONCT) stock?

A

You can purchase shares of Oncternal Therapeutics (NASDAQ: ONCT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Oncternal Therapeutics's (ONCT) competitors?

A

Other companies in Oncternal Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Vincerx Pharma (NASDAQ:VINC), Serina Therapeutics (AMEX:SER), Acurx Pharmaceuticals (NASDAQ:ACXP) and T2 Biosystems (NASDAQ:TTOO).

Q

What is the target price for Oncternal Therapeutics (ONCT) stock?

A

The latest price target for Oncternal Therapeutics (NASDAQ: ONCT) was reported by HC Wainwright & Co. on Monday, April 15, 2024. The analyst firm set a price target for 28.00 expecting ONCT to rise to within 12 months (a possible 209.39% upside). 7 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Oncternal Therapeutics (ONCT)?

A

The stock price for Oncternal Therapeutics (NASDAQ: ONCT) is $9.05 last updated May 9, 2024 at 5:55 PM EDT.

Q

Does Oncternal Therapeutics (ONCT) pay a dividend?

A

There are no upcoming dividends for Oncternal Therapeutics.

Q

When is Oncternal Therapeutics (NASDAQ:ONCT) reporting earnings?

A

Oncternal Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Q

Is Oncternal Therapeutics (ONCT) going to split?

A

There is no upcoming split for Oncternal Therapeutics.

Q

What sector and industry does Oncternal Therapeutics (ONCT) operate in?

A

Oncternal Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch